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stasis the expression of hepatic Mrp2 (ABCC2) is down-Dietrich Keppler (Heidelberg, Germany), who dis-
regulated whereas Mrp3 (ABCC3) is up-regulated incussed multidrug resistance protein 2 (MRP2) in hepato-
hepatocytes and cholangiocytes. Mdr1 (ABCB1), andcytes, opened session 7. He reported that MRP2 has been
the sister of P-glycoprotein (ABCB11, aka BSEP) arepurified to homogeneity as a 190-kD glycoprotein that
up-regulated and minimally down-regulated, respec-exhibits substrate-stimulated ATPase activity and ATP-
tively, in the liver. Following cholestasis, urinary bile saltdependent transport after reconstitution in proteolipo-
excretion is substantially increased and the ileal sodium-somes [1]. In addition, he demonstrated that prototypic
dependent bile salt transporter, Isbt (Slc10a2), which issubstrates for recombinant MRP2 include the glutathi-
expressed on the luminal membrane of the proximalone conjugate leukotriene C4, 17-glucuronosyl estra-
tubule (and normally reabsorbs bile salts from the glo-diol, and glucuronosyl bilirubin. In addition, a mutation
merular filtrate), is down-regulated. In contrast to theleading to the loss of Arg1392 and Met1393 from the
liver, Mrp2, which also is expressed at the luminal mem-second ATP-binding domain of human MRP2 causes
brane of the renal proximal tubule, is post-transcription-impaired maturation and trafficking of the mutant MRP2
ally up regulated. Mrp3 is expressed on the basolateralprotein from the endoplasmic reticulum to the Golgi
membrane of the proximal tubule of rat kidney andcomplex [2]. Studies on structural requirements for the
doesn’t change during cholestasis. Mrp2 and Mrp3 alsoapical sorting of MRP2 indicate that the apical localiza-
are expressed on the luminal and basolateral membranestion is only impaired when GFP-MRP2 is carboxy-termi-
of the intestine, respectively. However, the levels of ex-nally truncated by 15 or more amino acids [3].
pression vary reciprocally, with Mrp2 expression highestBruce Stanton (Hanover, New Hampshire, USA) dis-
in the duodenum while the highest expression of Mrp3cussed the importance of the PDZ interacting domain
is in the ileum and colon. Mdr1 also is expressed predom-in regulating the polarized expression of CFTR to the
inantly in the distal intestine on the luminal membraneapical membrane in renal and airway epithelial cells
and together with intestinal Mrp2 is down-regulated after[4, 5]. He showed that deletion of the PDZ interacting
chronic bile duct ligation. Recent studies indicate thatdomain abrogates the polarized expression of CFTR to
the Mrp2 promoter contains an RAR:RXR cis ele-the apical membrane and eliminates CFTR-mediated
ment and that interleukin-1 (IL-1) may suppress Mrp2Cl secretion. Pulse chase and selective cell surface bio-
promoter induction in vitro [6]. Preliminary studies indi-tinylation studies revealed that the PDZ interacting do-
cate that CBDL down-regulates liver Mrp2 RNA andmain is not an apical membrane-sorting motif. However,
protein in association with a loss of RAR and RXRdeletion of the PDZ interacting domain reduced the
nuclear proteins, and diminished binding of RAR:RXRhalf-life of CFTR in the apical plasma membrane. Thus,
to the Mrp2 promoter. In contrast, renal Mrp2 proteinselective retention in the apical membrane results in the
is up-regulated, RNA is unchanged, and there is no changepolarization of CFTR to the apical membrane. Finally,
in renal RAR and RXR nuclear protein or RNA.deletion of the PDZ interacting domain had no effect
Cytokine treatment of primary hepatocytes reduceson CFTR endocytosis from the apical membrane, but
RXR nuclear protein levels [7]. These studies indicatedramatically reduced the recycling of CFTR from an
that CBDL-induced cholestasis leads to differences inendosomal pool back to the apical plasma membrane. He
expression of the same ABC transporter in liver andconcluded that by regulating apical membrane recycling,
kidney, and that these differences may relate to organthe PDZ interacting domain results in the apical polar-
specific effects of ligand-mediated nuclear receptor regu-ization of CFTR.
lation of gene expression. Preservation of Mrp2 expres-In his lecture, James L. Boyer (New Haven, Connecti-
sion in kidney may permit urinary excretion of toxiccut, USA) spoke about molecular regulation of ABC
organic anions and xenobiotics when biliary excretion istransporters in liver, kidney and intestine in obstructive
cholestasis. He demonstrated that in obstructive chole- impaired.
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dependent apical excretion of p-aminohippurate andThis session was opened by Gerhard Burckhardt
probably also of other organic anions [5]. In summary,(Go¨ttingen, Germany). He summarized “the role of or-
OATs are involved in renal drug excretion and play anganic anion transporters (OATs) in the uptake of drugs
important role in the pharmacokinetics and nephrotoxic-into renal cells” [1]. OAT1 (SLC22A6) is located at the
ity of renally eliminated drugs.basolateral membrane of S2 proximal tubule epithelial
Ernst Petzinger (Giessen, Germany) summarized thecells of rat and human kidney. It exchanges intracellu-
current knowledge of the second family or superfamilylar -ketoglutarate against extracellular organic anions,
of organic anion transporters, namely the so-called “or-thereby driving organic anion uptake against the prevail-
ganic anion transporting polypeptides [rodents: Oatpsing electrochemical potential difference. In flounder re-
(Slc21a); humans OATPs (SLC21A)].” Oatps/OATPsnal OAT1, two positively charged, conserved amino
were first cloned from rat and human liver, where theyacids (K394 and R478) have been identified to be essen-
mediate sodium-independent basolateral (sinusoidal)tial for interaction with dicarboxylates. In all species
uptake of a large variety of amphipathic, albumin-boundOAT1 exhibits a broad substrate specificity and is re-
organic anions including bile salts, bromosulfophthalein,sponsible for uptake of most amphiphilic organic anions
steroid-conjugates, thyroid hormones, drugs (such as car-into proximal tubule cells. Besides classical organic anions,
diac glycosides, ACE-inhibitors, HMG-CoA reductasefor example, p-aminohippurate, its substrate spectrum
inhibitors), oligopeptides and natural hepatotoxins (forincludes numerous drugs (such as, -lactam antibiotics,
example, phalloidin, ochratoxin A, microcystin) [6]. Mean-antiviral drugs), nephrotoxins (such as, ochratoxin A)
while at least 11 rat, 8 mouse and 9 human Oatps/OATPsand heavy metal chelators [for example, 2,3-dimercapto-
have been identified and shown to be expressed, to vary-propane-1-sulfonate (DMPS)] [2, 3]. Closely related to
ing degrees, in multiple tissues including liver (rat Oatp1,OAT1 is OAT3 (SLC22A8), which exhibits a similar
rOatp2, rOatp4, hOATP-B, hOATP-C, hOATP8), intes-localization and similar polyspecific substrate transport
properties as OAT1. However, OAT3 cannot exchange tine (rOatp3), blood-brain barrier (rOatp2, hOATP-A),
choroid plexus (rOatp1/3, rOatp2), retina (rOatp2), pla-intracellular -ketoglutarate for extracellular organic
anions. OAT2 (SLC22a7) and OAT4 are more distantly centa (hOATP-B) and testis (hOATP-F) [6–10]. The
Petzinger group has identified four new Oatp-homologsrelated to OAT1/OAT3. Although OAT2 and OAT4
are polyspecific transporters, they cannot mediate -keto- in the cattle that show high amino acid sequence identi-
ties with the human OATPs. Especially, three cattleglutarate/organic anion exchange. OAT2 is expressed in
the liver and also in the kidneys of female rats [4]. OAT4 Oatps were identified in the adrenal glands, where they
are supposed to mediate high affinity transport of themay be localized at the apical membrane of human renal
proximal tubule cells and may be involved in the excre- cardiac glycoside ouabain, which might represent an en-
dogenous “digitalis-like factor” synthesized within adre-tion of organic anions into the urine. However, the multi-
drug resistance protein Mrp2 is responsible for ATP- nal glands of animals and man. Hence, Oatps/OATPs
